-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CB-03 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-03 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-03 in Epilepsy Drug Details: CB-03 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amitriptyline Hydrochloride in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amitriptyline Hydrochloride in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amitriptyline Hydrochloride in Chemotherapy Induced Peripheral Neuropathy Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amitriptyline Hydrochloride in Erythromelalgia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amitriptyline Hydrochloride in Erythromelalgia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amitriptyline Hydrochloride in Erythromelalgia Drug Details: Amitriptyline hydrochloride is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Levamlodipine + Telmisartan) in Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Levamlodipine + Telmisartan) in Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Levamlodipine + Telmisartan) in Hypertension Drug Details: LodienT, a fixed-dose combination...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-544 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-544 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-544 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: SI-544...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NAVX-010 in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NAVX-010 in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NAVX-010 in Chemotherapy Induced Peripheral Neuropathy Drug Details: NAVX-010 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XEN-1101 in Tonic-Clonic (Grand Mal) Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XEN-1101 in Tonic-Clonic (Grand Mal) Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XEN-1101 in Tonic-Clonic (Grand Mal) Seizure Drug Details: XEN-1101 (1OP-2198)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OLP-1002 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OLP-1002 in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OLP-1002 in Osteoarthritis Pain Drug Details: OLP-1002 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy Drug Details: Tetrodotoxin (TTX,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XEN-1101 in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XEN-1101 in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XEN-1101 in Major Depressive Disorder Drug Details: XEN-1101 (1OP-2198) is under...